Document text
Principal Investigator: David Beck
Organization: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Fiscal Year: 2024
Award: $606,951
Funding agency: National Institute of Arthritis and Musculoskeletal and Skin Diseases
Project Summary (<30 lines):
VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a newly identified
inflammatory and hematologic disease caused by somatic mutations in UBA1. Individuals with UBA1 mutations
have clinical manifestations similar to well-established rheumatic diseases such as rheumatoid arthritis and giant
cell arteritis but have unique manifestations including elevated mortality and treatment-refractory disease.
1/14,000 individuals are affected by VEXAS syndrome, and there are no effective treatments due to a limited
understanding of pathogenesis. We propose to further the mechanistic understanding of the disease as a first
step in developing treatments.
VEXAS syndrome is caused by hypomorphic mutations in UBA1 that lead to a reduction in global ubiquitylation.
UBA1 mutations are acquired and occur in the earliest bone marrow progenitor cells, become lineage restricted,
and accumulate within the myeloid lineage and are absent in lymphocytes. We have extensively studied cellular
models and patient derived cells to better understand the mechanism of disease in VEXAS syndrome. We have
identified multiple activated inflammatory pathways, although given the complexity of treatments and symptoms
in patients, these have not revealed pathogenic processes. Similarly, in UBA1 mutant cells there is activation of
the unfolded protein response likely due to accumulation of proteins intended to be degraded. Given the severity
of the disease, the lack of effective therapies, and the limited utility of cellular models to date, we propose here
to focus our work on our newly established mouse models of VEXAS syndrome to understand the cellular and
molecular mechanisms leading to disease. To this end, we will utilize conditional knockout (cKO) UBA1 and
conditional knock-in (cKI) UBA1 VEXAS mutations transgenic mouse lines to determine the contribution of
specific lineages to inflammation, the types of inflammation, downstream pathways mediating inflammation and
finally potential ways to reverse disease. We will study our Uba1 cKO, and cKI lines in bone marrow progenitor,
myeloid, B- and T-cells and determine the role of each cell type in driving organismal inflammation (Aim 1). We
will also look at these cell specific models to identify the molecular signaling pathways altered in cells mediating
inflammation (Aim 2). Finally, we will utilize small molecule activators and inhibitors in candidate pathways such
as ubiquitylation and the unfolded protein response to try to reverse inflammation in mouse and cellular models.
Our overall goal is to better define VEXAS syndrome inflammation and molecular signing to enable improved
therapies.
Terms: <20S Catalytic Proteasome><20S Core Proteasome><20S Proteasome><20S Proteosome><APF-1><ATP-Dependent Proteolysis Factor 1><Affect><American><Animal Model><Animal Models and Related Studies><Atrophic Arthritis><Automobile Driving><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><Biochemistry><Biological Chemistry><Blood><Blood Diseases><Blood Precursor Cell><Blood Reticuloendothelial System><Bone Marrow><Bone Marrow Reticuloendothelial System><Brachydanio rerio><Cell Body><Cell Communication and Signaling><Cell Line><Cell Signaling><Cell model><CellLine><Cells><Cellular model><Chemicals><Clinical><Clonal Expansion><Cranial Arteritis><Cultured Cells><Cytoplasm><Danio rerio><Disadvantaged><Disease><Disorder><Enzyme Activation><Enzyme Gene><Enzymes><Exhibits><Genetic Alteration><Genetic Change><Genetic defect><Giant Cell Arteritis><Goals><HMG-20><Hematologic Diseases><Hematological Disease><Hematological Disorder><Hematopoiesis><Hematopoietic><Hematopoietic Cellular Control Mechanisms><Hematopoietic Progenitor Cells><Hematopoietic stem cells><High Mobility Protein 20><Horton Disease><Horton Giant Cell Arteritis><Horton's Giant Cell Aortitis><Immune><Immunes><Individual><Inflammation><Inflammatory><Intracellular Communication and Signaling><Isoforms><Knock-in><Lead><Link><LoxP-flanked allele><Lymphatic cell><Lymphocyte><Lymphocytic><Lymphoid><Lymphoid Cell><Macropain><Macroxyproteinase><Mediating><Mice><Mice Mammals><Modeling><Molecular><Morbidity><Morbidity - disease rate><Multicatalytic Proteinase><Murine><Mus><Musculoskeletal Pain Disorder><Mutation><Myelogenous><Myeloid><Myeloid Cells><Pathogenesis><Pathogenicity><Pathway interactions><Patients><Pb element><Phenotype><Post-Translational Modification Protein/Amino Acid Biochemistry><Post-Translational Modifications><Post-Translational Protein Modification><Post-Translational Protein Processing><Posttranslational Modifications><Posttranslational Protein Processing><Process><Progenitor Cells><Prosome><Proteasome><Proteasome Endopeptidase Complex><Protein Isoforms><Protein Modification><Proteins><Proteomics><Proteosome><Refractory Disease><Regulation><Resistance><Rheumatic Diseases><Rheumatism><Rheumatoid Arthritis><Rheumatologic Diseases><Rheumatologic Disorder><Role><Severity of illness><Signal Pathway><Signal Transduction><Signal Transduction Systems><Signaling><Somatic Mutation><Strains Cell Lines><Symptoms><Syndrome><T-Cells><T-Lymphocyte><Temporal Arteritis><Transgenic Mice><Transplantation><Ubiquitin><Vacuole><Work><Zebra Danio><Zebra Fish><Zebrafish><autoinflammatory><biological signal transduction><blood cell formation><blood cell progenitor><blood disorder><blood progenitor><blood stem cell><blood-forming stem cell><cell type><conditional knock-out><conditional knockout><cultured cell line><disease severity><driving><effective therapy><effective treatment><experiment><experimental research><experimental study><experiments><fitness><floxed><floxed allele><genome mutation><heavy metal Pb><heavy metal lead><hematopoietic progenitor><hematopoietic stem progenitor cell><hemopoietic><hemopoietic progenitor><hemopoietic stem cell><improved><inhibitor><insight><knockin><lymph cell><model of animal><mortality><mouse model><multicatalytic endopeptidase complex><murine model><mutant><pathway><progenitor><resistant><response><rheumatic arthritis><small molecule><social role><somatic variant><stem cells><systemic inflammation><systemic inflammatory response><thymus derived lymphocyte><transplant>